Parallel study as pilot for long half life drug [Design Issues]

posted by d_labes  – Berlin, Germany, 2012-05-07 18:24 (5148 d 08:14 ago) – Posting: # 8526
Views: 5,711

Dear Dan!

❝ ... The CV% you get from the pilot is the total CV%, right. You use this to calculate your sample size for the pivotal study but it does not predetermine the design of the pivotal study.


Totally :confused: Can you please elaborate what this means?

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
139 visitors (0 registered, 139 guests [including 52 identified bots]).
Forum time: 02:39 CEST (Europe/Vienna)

Outside his own ever-narrowing field of specialization,
a scientist is a layman.
What members of an academy of science have in common
is a certain form of semiparasitic living.    Erwin Chargaff

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5